EICHOR
● Active Not Recruiting
Trial of Sibeprenlimab in the Treatment of A Nephropathy (IgAN)
Condition: Immunoglobulin A Nephropathy · Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
About this study
To Evaluate the Efficacy and Safety of Sibeprenlimab Administered Subcutaneously in Subjects with Primary Immunoglobulin A Nephropathy
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (308)
| University of Alabama at Birmingham - Site #336 | Birmingham, Alabama, United States | — |
| Mayo Clinic Arizona - Site #363 | Phoenix, Arizona, United States | — |
| University of Arkansas for Medical Sciences - Site #353 | Little Rock, Arkansas, United States | — |
| Amicis Research Center - Site #341 | Granada Hills, California, United States | — |
| University of CA San Diego - Site #351 | La Jolla, California, United States | — |
| California Institute of Renal Research - Site #371 | La Mesa, California, United States | — |
| Loma Linda University Health Care Clinical Trial Center Clinic - Site #372 | Loma Linda, California, United States | — |
| Academic Medical Research Institute - Site #333 | Los Angeles, California, United States | — |
| Kaiser Permanente - Southern California Permanente Medical Group SCPMG - LAMC - Site #325 | Los Angeles, California, United States | — |
| Stanford University - Site #370 | Palo Alto, California, United States | — |
| North America Research Institute - Site #335 | San Dimas, California, United States | — |
| University of California, San Francisco - Site #377 | San Francisco, California, United States | — |
+ 296 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.